SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-17-002915
Filing Date
2017-03-31
Accepted
2017-03-31 15:54:09
Documents
99
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 NAVIDEA BIOPHARMACEUTICALS FORM 10-K navb_10k.htm 10-K 3293933
2 ARTICLES OF INCORPORATION / BYLAWS navb_ex3-1.htm EX-3.1 90794
3 SUBSIDIARIES OF THE REGISTRANT navb_ex21-1.htm EX-21.1 5546
4 CONSENTS OF EXPERTS AND COUNSEL navb_ex23-1.htm EX-23.1 4889
5 CONSENTS OF EXPERTS AND COUNSEL navb_ex23-2.htm EX-23.2 4017
6 POWER OF ATTORNEY navb_ex24-1.htm EX-24.1 20568
7 CERTIFICATION navb_ex31-1.htm EX-31.1 10476
8 CERTIFICATION navb_ex31-2.htm EX-31.2 10393
9 CERTIFICATION navb_ex32-1.htm EX-32.1 5789
10 CERTIFICATION navb_ex32-2.htm EX-32.2 5779
11 IMAGE navb_comparison.jpg GRAPHIC 24694
  Complete submission text file 0001654954-17-002915.txt   8153985

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT navb-20161231.xml EX-101.INS 1080378
13 XBRL TAXONOMY EXTENSION SCHEMA navb-20161231.xsd EX-101.SCH 74411
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20161231_cal.xml EX-101.CAL 92521
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20161231_def.xml EX-101.DEF 140393
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20161231_lab.xml EX-101.LAB 488036
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20161231_pre.xml EX-101.PRE 324481
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35076 | Film No.: 17730211
SIC: 2835 In Vitro & In Vivo Diagnostic Substances